Scientists have made a breakthrough in understanding how Alzheimer’s disease develops, and a decades-old drug could be the ...
Studies reveal the therapeutic mechanism of action for levetiracetam to prevent the production of Aβ and, consequently, downstream irreversible damage.
The drug would need to be taken long before symptoms first appear—but it could be used to help protect at-risk individuals.
While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in ...
Dec. 9, 2003 (Boston) -- An unknown number of physicians prescribe levetiracetam (Keppra) off-label as a single-drug therapy for epilepsy, but researchers in California and Minnesota have found cause ...
Am J Health Syst Pharm. 2009;66(6):541-561. Shorvon et al. [20] conducted a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and tolerability of levetiracetam ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results